A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy

BACKGROUND: Intravenous glucocorticoids (ivGC) have been recommended as a first-line treatment of moderate-to-severe and active thyroid-associated ophthalmopathy (TAO). However, not all patients are responsive to ivGC. The identification of potential factors used to predict their efficacy and the se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Endocr Disord
Autors principals: Wang, Yang, Zhang, Shuo, Zhang, Yidan, Liu, Xingtong, Gu, Hao, Zhong, Sisi, Huang, Yazhuo, Fang, Sijie, Sun, Jing, Zhou, Huifang, Fan, Xianqun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5819263/
https://ncbi.nlm.nih.gov/pubmed/29463244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-018-0240-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars